Publications
210
Citations
6,113
Est. group size
~1
Recurring co-author estimate
Active years
25
Publishing since 2002
Stefanie Galbán's research focuses on cancer biology and imaging, with particular attention to diffuse midline glioma (a type of brain tumor), lung cancer resistance to targeted therapies like KRAS inhibitors, and quantitative CT-based imaging methods for chronic obstructive pulmonary disease (COPD). Work spans laboratory studies of tumor microenvironments and drug resistance mechanisms as well as computational approaches to scoring lung disease severity from medical imaging. The publication record suggests collaborative, multi-project research combining oncology, immunology, and medical imaging analysis.
Publication output was relatively steady and modest from 2017-2022, then increased sharply in 2023-2024 before tapering in the following years, though 2026 entries suggest continued active output.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Identification of molecularly targeted therapy-induced immunopeptidome in diffuse midline glioma (DMG)
Neoplasia · 2026
- Elastic parametric response mapping: quantitative CT scoring for local COPD severity
Thorax · 2026
- STREAM: State Trajectory Representation & Evolution-Aware Monitoring
medRxiv · 2026
- Abstract B023: Identification of TME-dependent resistance and emergence of persister cells to KRAS inhibition
Cancer Research · 2026
- Abstract B025: Potential limitation of oncogenic KRAS-targeted therapy in lung cancer due to stromal remodeling
Cancer Research · 2026
- Abstract B029: Immune checkpoint mediated resistance to KRASG12D inhibition
Cancer Research · 2026
- P02.02 Identification of tumor microenviornment-dependent resistance and emergence of persister cells to KRAS inhibition
Poster presentations · 2026
- Abstract 2834: Identification of CXCL10-CXCR3 axes as mediators of radioresistance in diffuse midline glioma (DMG)
Cancer Research · 2026
- Abstract 199: Identification of oncohistone-dependent changes in chromatin accessibility and the tumor microenvironment in a new inducible and reversible H3.3K27M mouse model of diffuse midline glioma (DMG).
Cancer Research · 2026
- Feature-Based Parametric Response Mapping on Thoracic Computed Tomography for Robust Disease Classification in COPD
medRxiv · 2026
- Oncohistone inhibition reshapes tumor–microenvironment communication in Diffuse Midline Glioma (DMG)
bioRxiv (Cold Spring Harbor Laboratory) · 2026
- KRASG12D drives immunosuppression in lung adenocarcinoma through paracrine signaling
JCI Insight · 2025
- Quantitative CT Scoring for Local COPD Severity
medRxiv · 2025
- Abstract 5248: Identification of a chromatin-remodeling peptide in diffuse midline glioma by immunopeptidomics
Cancer Research · 2025
- Abstract 6698: Inducible miRNA therapeutics: A multi-targeted strategy for treating diffuse midline gliomas
Cancer Research · 2025
- Cancer Research×18
- medRxiv×7
- Neoplasia×5
- bioRxiv (Cold Spring Harbor Laboratory)×4
- Molecular Cancer Therapeutics×3
- Swapna Joshi
Medicine · Indiana University
- Ajay Patel
Medicine · Indiana University
- Kamalakannan Palanichamy
Medicine · The Ohio State University
- Disha Patel
Medicine · The Ohio State University
- Jie Zhang
Medicine · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 20, 2026.
Claim or correct this profile